Company/Division name | Sterling Pharma Solutions |
Type of work | Manufacturing |
Reshoring category: | Foreign Direct Investment |
Year reshoring announced: | 2020 |
Domestically, the work will be done: | In-house |
Country(ies) from which reshored: | United Kingdom |
City reshored to: | Germantown |
State(s) reshored to: | WI |
If relevant, work nearshored to: | - |
Industry(ies): | Chemicals |
Product(s) reshored | API, Active Pharmaceutical Ingredients |
What domestic positive factors made reshoring more attractive? | Lead time/Time to market, Proximity to customers/market, Skilled workforce availability/training |